Tag Archives: Patients

FDA Approves Zolgensma (onasemnogene abeparvovec-xioi) Gene Therapy to Treat Pediatric Patients with Spinal Muscular Atrophy

FDA Approves Zolgensma (onasemnogene abeparvovec-xioi) Gene Therapy to Treat Pediatric Patients with Spinal Muscular Atrophy Print this page May 24, 2019 — The U.S. Food and Drug Administration today approved Zolgensma (onasemnogene abeparvovec-xioi), the first gene therapy approved to treat children less than two years of age with spinal muscular atrophy (SMA), the most severe… Read More »

Barriers to patients accessing their health data are falling

While the Office of the National Coordinator for HIT continues to remind providers of patients’ rights to electronically view, download and transmit their health information via application programming interfaces, many hospitals are already complying. Since 2014, eligible hospitals have been required to provide patients with the capability to get their information, and in 2017 nearly… Read More »

Artificial intelligence can identify at-risk patients, inform care and improve disease prevention

There’s no shortage of buzz around artificial intelligence and its potential impact on a variety of areas within healthcare, from patient care to revenue cycle operations. There is an emerging trend toward AI assets that amplify the value of patient data and provide an extendable, scalable pathway to effective primary disease prevention. That’s something that… Read More »